建議您使用以下瀏覽器觀看合一網站,
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?
- 開啟新分頁(紅色框)
- 於搜尋框中打入Edge(紅色框),並按搜尋(藍色框)
- 點擊【立即啟動】(藍框處)打開 Microsoft Edge
Title
Oneness announces the information about the investor's conference of 2024 Q1.
Oneness Biotech Co., Ltd. receives a Saudi Arabian patent titled "TOPICAL FORMULATION FOR PROMOTING WOUND HEALING" on Fespixon cream (Research code: ON101).
Announce the change of the internal audit officer.
The board of directors of the Company approved removal of the noncompete clause for managers.
Annouce the change of the spokesperson.
Annouce the change of the general manager.
Oneness Board of Directors resolved to convene the Annual Shareholders' Meeting of 2024.
The Board of Directors resolved to the new common share issuance through the increase of capital by capitalization of capital surplus
The Board of Directors resolved to distribute dividends.
The Company's 2023 consolidated financial statements have been approved by the Board of Directors
Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its Board of Directors resolve not to distribute dividends
Oneness announces on behalf of major subsidiary Cotton Field Organic Farm Inc. about its BOD resolution to convene the 2024 Annual Shareholders' meeting
Oneness Biotech Co.,LTD receives a Taiwan patent on antagonistic LAG-3 aptamers.
News-Oneness has been selected in the S&P Global Sustainability Yearbook for two consecutive years
Submission of a phase II clinical trial protocol for subcutaneous injection formulation of FB825 in patients with moderate-to-severe atopic dermatitis
建議您使用以下瀏覽器觀看合一網站,
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?